You are using an older browser version. Please use a supported version for the best MSN experience.

Heart risk from common painkillers: study

Press AssociationPress Association 28/09/2016

Common painkillers used by millions of people in the UK are linked to an increased risk of heart failure, experts warn.

Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen could increase the risk of being admitted to hospital with the heart problem, a study has found.

Previous studies have linked the drugs to abnormal heart rhythm - which can cause heart failure - and an increased risk of heart attack and stroke if taken regularly.

The drugs - together with a sub-group of anti-inflammatories known as selective COX-2 inhibitors - are used to control pain and inflammation and are commonly taken by people with arthritis.

The new study, published in the British Medical Journal, used data for almost 10 million NSAIDs users from the UK, the Netherlands, Italy and Germany, who started NSAID treatment between 2000 and 2010.

Overall, 92,163 hospital admissions for heart failure were identified among the group.

The study found people who had taken any NSAID in the previous 14 days had a 19 per cent increased risk of hospital admission for heart failure compared with people who had used NSAIDs at any point in the past.

The risk of admission for heart failure increased for seven traditional NSAIDs (diclofenac, ibuprofen, indomethacin, ketorolac, naproxen, nimesulide, and piroxicam) and two COX 2 inhibitors (etoricoxib and rofecoxib).

The increased risk of hospital admission ranged from 16 per cent for naproxen to 83 per cent for ketorolac.

Researchers also found the risk of heart failure doubled for diclofenac, etoricoxib, indomethacin, piroxicam, and rofecoxib used at very high doses, although they stressed this should be interpreted with caution.

Even medium doses of indomethacin and etoricoxib were associated with increased risk, the study says, but there is no evidence celecoxib increases the risk of admission for heart failure at commonly used doses.

In an accompanying editorial, two Danish health researchers said that owing to the widespread use of NSAIDs, "even a small increase in cardiovascular risk is a concern for public health".

Professor Peter Weissberg, medical director at the British Heart Foundation, said: "This large observational study reinforces previous research showing that some NSAIDs, a group of drugs commonly taken by patients with joint problems, increase the risk of developing heart failure.

"Since heart and joint problems often co-exist, particularly in the elderly, this study serves as a reminder to doctors to consider carefully how they prescribe NSAIDs, and to patients that they should only take the lowest effective dose for the shortest possible time."

The Proprietary Association of Great Britain, which represents manufacturers of branded over-the-counter medicines, stressed the people in the study were given NSAIDs on prescription.

Chief executive John Smith said: "Prescribed NSAIDs contain a higher dosage than medicines available over-the-counter, which the authors acknowledge would typically be used by younger people, at lower doses and for shorter durations than those prescribed.

"The authors admit that the study has several limitations. The study does not provide data on absolute risk, therefore the probability of these people developing heart failure without the use of NSAIDs is unknown."

image beaconimage beaconimage beacon